Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer
NCT06499610
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Irinotecan Hydrochloride Liposome Injection
Sponsor
First Affiliated Hospital Xi'an Jiaotong University